Rhythm Pharmaceuticals Inc.
RYTM | NASDAQ
$105.02
-$5.66 (-5.11%)
At close: Nov 5, 2026, 4:00 PM ET
$105.00
-$0.02 (-0.02%)
After-hours:
Nov 5, 2026, 5:08 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -34.42 | -12.90 | -14.37 | -8.30 | -7.28 | -10.04 |
PEG Ratio | 1.21 | -0.36 | 1.63 | -0.05 | 0.14 | 0.50 |
PS Ratio | 36.66 | 26.24 | 34.24 | 64.21 | 156.95 | n/a |
PB Ratio | 25.76 | 20.75 | 15.62 | 5.74 | 1.74 | 7.88 |
P/FCF Ratio | -59.64 | -29.98 | -19.47 | -8.54 | -3.27 | -10.74 |
P/OCF Ratio | -60.13 | -29.98 | -19.47 | -8.75 | -3.39 | -10.76 |
OCF/S Ratio | -60.96 | -87.51 | -175.85 | -733.68 | -4.63K | n/a |
Debt / Equity Ratio | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 |
Quick Ratio | 4.16 | 3.08 | 5.43 | 8.83 | 7.10 | 10.10 |
Current Ratio | 4.41 | 3.24 | 5.58 | 8.90 | 7.10 | 10.10 |
Asset Turnover | 0.40 | 0.33 | 0.23 | 0.06 | 0.01 | n/a |
Interest Coverage | -9.33 | -12.89 | -13.27 | -34.45 | n/a | n/a |
Return on Equity | -72.79% | -158.37% | -108.79% | -68.54% | -24.50% | -78.50% |
Return on Assets | -40.93% | -66.43% | -55.50% | -47.35% | -21.13% | -69.88% |
Return on Invested Capital | -51.22% | -95.93% | -66.24% | -52.18% | -59.32% | -80.52% |
Dividend Yield | n/a | 0.12% | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | -1.52% | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | -2.59% | n/a | n/a | n/a | n/a |
Gross Profit Margin | 89.73% | 89.73% | 87.99% | 90.98% | 81.01% | n/a |
Net Profit Margin | -103.57% | -200.27% | -238.52% | -766.22% | -2.21K% | n/a |
Pretax Profit Margin | -103.31% | -200% | -237.79% | -766.22% | -2.21K% | n/a |
Operating Profit Margin | -101.19% | -204.04% | -238.10% | -757.92% | -5.39K% | n/a |
FCF Margin | -61.46% | -87.51% | -175.91% | -751.79% | -4.8K% | n/a |
EBITDA Margin | -91.76% | -182.97% | -217.57% | -737.14% | -2.17K% | n/a |
Add to Watchlist
Select watchlists to add or remove RYTM